Trial Profile
Phase II study of SB 9200 in patients with Hepatitis B Virus (HBV) Infection
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Inarigivir soproxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 14 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 May 2016, as reported in a Spring Bank Pharmaceuticals media release.
- 29 Apr 2015 New trial record